# A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children

> **NCT00319670** · PHASE4 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 25 (—)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** MiraLax

## Key facts

- **NCT ID:** NCT00319670
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-05
- **Final completion:** —
- **Target enrollment:** 25 (—)
- **Last updated:** 2013-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319670, "A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00319670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*